Compare Firy Inc. (FIRY) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Firy Inc. vs Pfizer Inc — how do they compare? Firy Inc. trades at $11.97 (market cap $196.97M), while Pfizer Inc trades at $27.75 (market cap $159.59B). The key difference: Pfizer Inc is far larger — about 810.2× Firy Inc.'s market cap, and Pfizer Inc pays a 6.14% dividend while Firy Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Pfizer Inc for 158 Days on average.
| FIRY | PFE | |
|---|---|---|
Market Cap | $196.97M | $159.59B |
Volume | 155,239 | 30,937,010 |
Sector | Technology | Health |
52-Week High | $13.10 | $29.02 |
52-Week Low | $2.28 | $23.67 |
Typical Hold Time | 13 Days | 158 Days |
Enterprise Value | $165.57M | $211.09B |
Dividend Yield | — | 6.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.02, down 3.69% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company shows a high gross margin of 87.76% but negative net income margin of -60.23% and significant cash burn. Recent developments include a $719 million legal victory and board additions, though revenue has declined from $270M in 2022 to $104M in 2025.
The outlook remains challenging with persistent losses and cash burn offset by potential from legal wins. Investment opportunity exists if the company can monetize legal judgments and stabilize operations, but risks include continued operational losses and uncertainty around cash flow sustainability.
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
